Gene Deletion Chemoselectivity: Codeletion of the Genes for P16(INK4), Methylthioadenosine Phosphorylase, and the Alpha

Total Page:16

File Type:pdf, Size:1020Kb

Gene Deletion Chemoselectivity: Codeletion of the Genes for P16(INK4), Methylthioadenosine Phosphorylase, and the Alpha University of Massachusetts Medical School eScholarship@UMMS Open Access Articles Open Access Publications by UMMS Authors 1996-03-01 Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy Zhi-Hao Chen University of Massachusetts Medical School Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/oapubs Part of the Cancer Biology Commons, and the Oncology Commons Repository Citation Chen Z, Zhang H, Savarese TM. (1996). Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy. Open Access Articles. Retrieved from https://escholarship.umassmed.edu/oapubs/371 This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. [CANCERRESEARCH56, 1083-1090, March1, 19961 Gene Deletion Chemoselectivity: Codeletion of the Genes for p16@'@4, Methylthioadenosine Phosphorylase, and the a- and @-Interferons in Human Pancreatic Cell Carcinoma Lines and Its Implications for Chemotherapy' Zhi-Hao Chen, Hongyang Zhang, and Todd M. Savarese2 Cancer Center, University of Massachusetts Medical Center, Worcester, Massachusetts 01655 ABSTRACT Loss of these “innocentbystander―genes may be significant, because loss of the expression of the proteins encoded by these genes may alter Pancreatic carcinoma cells lines are known to have a high incidence of cellular physiology and, as a consequence, the sensitivity of these homozygous deletion of the candidate tumor suppressor genepl6 (MTSJ/ cells to certain therapeutic agents. Because deletion of these innocent CDKN2), which resides in the chromosome 9p21 region. Here we: (a) examined a seties of these cell lines for the Incidence ofcodeletion of genes bystander genes occurs in cells undergoing oncogenic transformation located near p16, in particular, the gene for the enzyme 5'-deoxy-S'- but not in normal cells, it may be possible to design therapeutic methylthioadenosine phosphorylase (MTAP) and the genes of the IFN.a strategies that take advantage of these selective genetic losses. and 43 cluster (IFNs); and (b) investigated whether therapeutic strategies A potential example of this involves malignant cells that have could be developed that target malignant cells that have undergone the undergone genetic deletions in the chromosome 9p2l region. The codeletion of such genes. Five of the eight pancreatic carcinoma cell lines genes for two candidate tumor suppressor proteins, pl6'@4 and were plt$@, MTAP was codeleted in all five cases. Because MTAP phos. pl5@4'@, respectively referred to aspl6 (MTSI/CDK4I/CDKN2) and phorolyzes 5'-deoxy-S'-methylthioadenosine (MTA), generated as a by p15(MTS2),residecloseto oneanotherin thisregion(2). Bothof product of polyamine synthesis, to the salvageable purine base adenine, these proteins act to inhibit the catalytic activity of the cyclin-depend loss of this pathway in p16W, @f7@4p cells might sensitize these cells to methotrexate (MTX), the mechanism of action of which involves, in part, ent kinase 4 (or 6)-cyclin D complex, which in its active form an Inhibition of purine de novo synthesis. MTAP@normal keratinocytes phosphorylates the retinoblastoma protein Rb (3, 4); this phosphoryl and pancreatic carcinoma lines had relatively poor sensitivity, In terms of ation is thought to be a key step in the progression of cells from a efficacy, to the purine nucleotide-starving actions of MTX. This may be in restriction point late in G1 into S-phase (5). Genetic deletion or part due to the MTAP-dependent salvage of adenine moieties from endo functional inactivation via mutation of one or both of these cyclin genously generated MTA, because the MTAP inhibitor 5'-chloro.S'-de dependent kinase inhibitors might, in principle, contribute to a loss of oxyformycin A potentiates the antipurine actions of MTX in some of these the cell's ability to control cell cycle progression, a hallmark of MTAP@ @jflesAlso, exogenous MTA (10 gEM)reverses the growth-inhibi malignancy (2, 6). Indeed, homozygous deletion or point mutations of tory actions of MTh in these lines. In contrast, MTAP cell lines, which cannot recycle purines from endogenous MTA, have a relatively high the gene for p16 have been shown to occur in a variety of primary sensitivity to the antipurine actions of MTX, which is not modulated by malignancies (7—18).Where studied, the p1.5 gene, which resides 5'-chioro-S'-deoxyformycin A or exogenous MTA. Thus the MTAP loss in approximately 20 kb centromencally from p16 (2, 12), has been malignant cells may be an example of gene deletion chemoselectivity, in shown to be codeleted frequently in malignant cells that bear homozy which genetic deletions that occur as part of the oncogenic process render gous deletions of pitS (8, 9, 12, 14, 15). It has been suggested that these cells more sensitive to particular anticancer agents than normal homozygous deletions within the 9p2l region may be relatively cells, which have not undergone such deletions. We also examined whether common in particular cancers, because such deletional events could the loss of IFN genes sensitize cells to the growth-inhibitory actions of inactivate pl6, plS, and possibly other tumor suppressor genes resid these cytokines. Three of the five pltS@cell lines bore homozygous dele ing in this region simultaneously, resulting in a selective growth tions of IFNAJ and IFNBJ genes, representing each end of the IFN-a41 gene duster; one cell line bore a codeletion ofthe IFNA1 gene but retained advantage (12). the IFNBJ locus. Whereas the cell lines that were most sensitive to the When such deletional events involving multiple loci take place growth-inhibitory effects 0fIFN.fi or WN-a2b tended to be those with IFN within the 9p2l region, a number of other neighboring genes can be deletions, there were enough exceptions to this pattern to indicate that the lost coincidentally. Examples of this include the gene that encodes the IFN genotype does not reliably predict IFN responsiveness. enzyme MTAP3 (MTAP), which is reported to reside less than 100 kb from pitS (19), and the IFN gene cluster, consisting of the WN-@3@ INTRODUCTION gene (IFNBJ) and at least 25 genes and pseudogenes for IFN-a (IFNA) and IFN-(&)(20), located approximately 500—1000kb in the Loss or inactivation of tumor suppressor genes occurs in many telomeric direction from p16 (19). MTAP is codeleted with a fre cancers (1). In some cases, both tumor suppressor gene alleles are lost quency of >85% in cell lines bearing pitS deletions, whereas the IFN by mechanisms involving genetic deletion, i.e. , homozygous deletion. gene cluster is deleted in whole or in part in >50% of p16-deficient As result of these events, genes that reside nearby but are otherwise cell lines (21). unrelated to these tumor suppressor genes can frequently be codeleted. Hypothetically, loss of either MTAP or the IFN genes might render malignant cells with 9p21 defects more sensitive to certain antineo Received 9/21/95; accepted 1/3/96. plastic agents than normal cells that have not undergone these genetic Thecostsof publicationof thisarticleweredefrayedin partby thepaymentof page charges. This article must therefore be hereby marked advertisement in accordance with deletions. MTAP phosphorolyzes the nucleoside MTA, a metabolite 18U.S.C.Section1734solelyto indicatethisfact. of S-adenosylmethionine produced during the synthesis of the poly I This work was supported by PHS Grant ROl CA-6378l (T. M. S.). The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the PHS. 3 The abbreviations used are: MTAP, 5'-deoxy-5'-methylthioadenosine phosphonyl 2 To whom requests for reprints should be addressed. at Cancer Center, Room HB-774, ase; 5'-CIF, 5'-chloro-5'-deoxyfonmycin A; LU, international unit; KGM, kenatinocyte University of Massachusetts Medical Center, 55 Lake Avenue North, Worcester, MA growth medium; MTA, 5'-deoxyS'-methylthioadenosine; MTX, methotrexate; MU, 3-(4,5- 01655. dimethylthiazol-2-yl)-2i-diphenyltetnazolium bromide; IC,,, 50% inhibitory concentration. 1083 p16. MTAP. AND 1FN DELETION AND CHEMOSELECTIVITY amines spermidine and spermine, to yield 5-methylthioribose-l-phos a solution of MiT (5 mg/mI dissolved in PBS) were added directly to each phate, a methionine precursor, and adenine (22), which is converted to well, and the plate was incubated an additional 2 h at 37°C. A solution of 0.1 adenine nucleotides via adenine phosphoribosyltransferase (EC N HC1 and 10% Triton X-lOO in isopropanol was added to each well (1.2 ml) 2.4.2.7; Refs. 23 and 24). Thus, MTAP plays a critical role in to dissolve the colored metabolite of MTI', formazan. This solubilization was recycling adenine moieties from S-adenosylmethionine, derived orig facilitated by sonicating each well using a Branson 250 sonifier (Danbury, CT). An aliquot (300 @l)of each well was then transferred to individual wells inally from AlP, back to adenine nucleotide pools (25). MTAP in a 96-well plate, and the absorbance at 570 nan was measured in a Molecular deficient malignant cells, unable to metabolize MTA, simply excrete Devices (Sunnyvale, CA) plate reader against a background wavelength of 650 it (26). Loss of this adenine salvage pathway might sensitize p16@, nm. After substraction of background values (wells containing medium but no MTAP cells to the anticancer agent MTX, the mechanism of action cells), the absonbance values were plotted as a percentage of the absorbance of which involves, in part, purine nucleotide starvation via an inhibi value of control wells, in which cells were grown in the absence of MTX.
Recommended publications
  • Methylthioadenosine Phosphorylase (MTAP) Is Frequent in High-Grade Gliomas; Nevertheless, It Is Not Associated with Higher Tumor Aggressiveness
    cells Article 0 Loss of 5 -Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness Weder Pereira de Menezes 1, Viviane Aline Oliveira Silva 1 , Izabela Natália Faria Gomes 1 , Marcela Nunes Rosa 1 , Maria Luisa Corcoll Spina 1 , Adriana Cruvinel Carloni 1, Ana Laura Vieira Alves 1 , Matias Melendez 1, Gisele Caravina Almeida 2, Luciane Sussuchi da Silva 1 , Carlos Clara 3, Isabela Werneck da Cunha 4, Glaucia Noeli Maroso Hajj 4 , Chris Jones 5, Lucas Tadeu Bidinotto 1,6,7 and Rui Manuel Reis 1,8,9,* 1 Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo 14.784-400, Brazil; [email protected] (W.P.d.M.); [email protected] (V.A.O.S.); [email protected] (I.N.F.G.); [email protected] (M.N.R.); [email protected] (M.L.C.S.); [email protected] (A.C.C.); [email protected] (A.L.V.A.); [email protected] (M.M.); [email protected] (L.S.d.S.); [email protected] (L.T.B.) 2 Department of Pathology, Barretos Cancer Hospital, Barretos, São Paulo 14.784-400, Brazil; [email protected] 3 Department of Neurosurgery, Barretos Cancer Hospital, Barretos, São Paulo 14.784-400, Brazil; [email protected] 4 A.C Camargo Cancer Center, São Paulo, São Paulo 015.080-10, Brazil; [email protected] (I.W.d.C.); [email protected] (G.N.M.H.) 5 Institute of Cancer Research, London SW7 3RP, UK; [email protected] 6 Barretos School of Health Sciences, Dr.
    [Show full text]
  • The Two Tort Dit U Nonton Un Mountin
    THETWO TORT DIT USU 20180010132A1NONTONUN MOUNTIN ( 19) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2018 / 0010132 A1 MAVRAKIS et al. ( 43 ) Pub . Date : Jan . 11 , 2018 ( 54 ) INHIBITION OF PRMT5 TO TREAT Publication Classification MTAP - DEFICIENCY- RELATED DISEASES (51 ) Int . CI. C12N 15 / 113 ( 2010 .01 ) (71 ) Applicant : NOVARTIS AG , Basel (CH ) A61K 45 / 06 ( 2006 . 01) ( 72 ) Inventors : Konstantinos John MAVRAKIS , A61K 31 / 7088 (2006 . 01 ) Boston , MA (US ) ; Earl Robert COZK 16 / 40 ( 2006 .01 ) MCDONALD , III , Wayland , MA (US ) ; A61K 39 /395 ( 2006 . 01 ) Frank Peter STEGMEIER , Acton , GOIN 33 /574 (2006 . 01 ) A61K 39 / 00 ( 2006 .01 ) MA (US ) (52 ) U . S . CI. CPC . .. C12N 15 / 1137 ( 2013 .01 ) ; A61K 39 /3955 ( 73 ) Assignee : Novartis AG , Basel (CH ) ( 2013 .01 ) ; A61K 45 / 06 ( 2013 .01 ) ; GOIN 33 /574 ( 2013. 01 ) ; C12Y 201/ 01 (2013 .01 ) ; ( 21 ) Appl. No. : 15 /510 , 542 A61K 31 /7088 (2013 .01 ) ; CO7K 16 / 40 ( 2013 .01 ) ; A61K 2039 /505 (2013 . 01 ) ; C12N ( 22 ) PCT Filed : Sep . 9 , 2015 2310 / 14 (2013 . 01 ) ; C12N 2320 / 31 ( 2013 .01 ) ; ( 86 ) PCT No .: PCT/ IB2015 /056902 CO7K 2317/ 76 ( 2013 .01 ) $ 371 (c ) ( 1 ) , (57 ) ABSTRACT ( 2 ) Date : Mar. 10 , 2017 The invention provides novel personalized therapies , kits , transmittable forms of information and methods for use in treating patients having cancer , wherein the cancer is Related U . S . Application Data MTAP - deficient and / or MTA -accumulating and thus ame (60 ) Provisional application No . 62/ 131 ,437 , filed on Mar . nable to therapeutic treatment with a PRMT5 inhibitor. Kits , 11 , 2015 , provisional application No .
    [Show full text]
  • Specific Targeting of MTAP-Deleted Tumors with a Combination of 2 ′-Fluoroadenine and 5′-Methylthioadenosine
    Published OnlineFirst May 29, 2018; DOI: 10.1158/0008-5472.CAN-18-0814 Cancer Translational Science Research Specific Targeting of MTAP-Deleted Tumors with a Combination of 20-Fluoroadenine and 50-Methylthioadenosine Baiqing Tang, Hyung-Ok Lee, Serim S. An, Kathy Q. Cai, and Warren D. Kruger Abstract Homozygous deletion of the methylthioadenosine phos- dependent manner, shifting the IC50 concentration by one to phorylase (MTAP) gene is a frequent event in a wide variety of three orders of magnitude. However, in mice, MTA protected human cancers and is a possible molecular target for therapy. against toxicity from 2FA but failed to protect against 6TG. One potential therapeutic strategy to target MTAP-deleted Addition of 100 mg/kg MTA to 20 mg/kg 2FA entirely reversed tumors involves combining toxic purine analogues such as the toxicity of 2FA in a variety of tissues and the treatment was 60-thioguanine (6TG) or 20-fluoroadenine (2FA) with the well tolerated by mice. The 2FAþMTA combination inhibited À MTAP substrate 50-deoxy-50-methylthioadenosine (MTA). The tumor growth of four different MTAP human tumor cell lines þ rationale is that excess MTA will protect normal MTAP cells in mouse xenograft models. Our results suggest that 2FAþMTA from purine analogue toxicity because MTAP catalyzes the may be a promising combination for treating MTAP-deleted conversion of MTA to adenine, which then inhibits the con- tumors. version of purine base analogues into nucleotides. However, À in MTAP tumor cells, no protection takes place because Significance: Loss of MTAP occurs in about 15% of all adenine is not formed.
    [Show full text]
  • CDKN2A and MTAP Deletions in Peritoneal Mesotheliomas Are Correlated with Loss of P16 Protein Expression and Poor Survival
    Modern Pathology (2010) 23, 531–538 & 2010 USCAP, Inc. All rights reserved 0893-3952/10 $32.00 531 CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival Alyssa M Krasinskas1, David L Bartlett2, Kathleen Cieply1 and Sanja Dacic1 1Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA and 2Division of Surgical Oncology, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA Homozygous deletion of CDKN2A (p16) is one of the most common genetic alterations in pleural mesotheliomas, occurring in up to 74% of cases. MTAP resides in the same gene cluster of the 9p21 region and is co-deleted in the majority of CDKN2A deleted cases. This study examines the genetic alterations in peritoneal mesotheliomas, which may have a different pathogenesis than their pleural counterparts. Twenty-six cases of peritoneal mesotheliomas in a triplicate tissue microarray were studied. Dual-color fluorescence in situ hybridization was performed with CDKN2A and MTAP locus-specific probes. Nine of 26 (35%) peritoneal mesotheliomas had homozygous deletion of CDKN2A; MTAP was co-deleted in every case. All cases with CDKN2A deletions had loss of p16 protein expression; five cases had loss of p16 protein without evidence of CDKN2A deletions. All patients with CDKN2A deletions were men (P, NS) and were significantly older (mean, 63 years) than the patients with no deletions (mean, 52 years) (P ¼ 0.033, t-test). An association with asbestos exposure could not be proved in this study. Similar to pleural mesotheliomas, patients with CDKN2A deletions and loss of p16 protein expression had worse overall and disease-specific survival (P ¼ 0.010 and 0.006, respectively; Kaplan–Meier log rank).
    [Show full text]
  • Methylthioadenosine Phosphorylase at 1.7 Å Resolution Provides Insights Into Substrate Binding and Catalysis Todd C Appleby1, Mark D Erion2 and Steven E Ealick3*
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Research Article 629 The structure of human 5′-deoxy-5′-methylthioadenosine phosphorylase at 1.7 Å resolution provides insights into substrate binding and catalysis Todd C Appleby1, Mark D Erion2 and Steven E Ealick3* Background: 5′-Deoxy-5′-methylthioadenosine phosphorylase (MTAP) Addresses: 1Section of Biochemistry, Molecular and catalyzes the reversible phosphorolysis of 5′-deoxy-5′-methylthioadenosine Cell Biology, Cornell University, Ithaca, NY 14853, USA and 2Metabasis Therapeutics, Inc., 9390 Town (MTA) to adenine and 5-methylthio-D-ribose-1-phosphate. MTA is a by-product Center Drive, San Diego, California 92121, USA of polyamine biosynthesis, which is essential for cell growth and proliferation. and 3Department of Chemistry and Chemical This salvage reaction is the principle source of free adenine in human cells. Biology, Cornell University, Ithaca, NY 14853, USA. Because of its importance in coupling the purine salvage pathway to polyamine *Corresponding author. biosynthesis MTAP is a potential chemotherapeutic target. Email: [email protected] Results: We have determined the crystal structure of MTAP at 1.7 Å resolution Key words: methylthioadenosine phosphorylase, using multiwavelength anomalous diffraction phasing techniques. MTAP is a multiwavelength anomalous diffraction, purine trimer comprised of three identical subunits. Each subunit consists of a single nucleoside phosphorylase, salvage pathway α β β / domain containing a central eight-stranded mixed sheet, a smaller five- Received: 18 January 1999 stranded mixed β sheet and six α helices. The native structure revealed the Revisions requested: 17 February 1999 presence of an adenine molecule in the purine-binding site.
    [Show full text]
  • Concordance of Copy Number Loss and Down-Regulation of Tumor Suppressor Genes: a Pan-Cancer Study Min Zhao1 and Zhongming Zhao2,3,4,5*
    The Author(s) BMC Genomics 2016, 17(Suppl 7):532 DOI 10.1186/s12864-016-2904-y RESEARCH Open Access Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study Min Zhao1 and Zhongming Zhao2,3,4,5* From The International Conference on Intelligent Biology and Medicine (ICIBM) 2015 Indianapolis, IN, USA. 13-15 November 2015 Abstract Background: Tumor suppressor genes (TSGs) encode the guardian molecules to control cell growth. The genomic alteration of TSGs may cause tumorigenesis and promote cancer progression. So far, investigators have mainly studied the functional effects of somatic single nucleotide variants in TSGs. Copy number variation (CNV) is another important form of genetic variation, and is often involved in cancer biology and drug treatment, but studies of CNV in TSGs are less represented in literature. In addition, there is a lack of a combinatory analysis of gene expression and CNV in this important gene set. Such a study may provide more insights into the relationship between gene dosage and tumorigenesis. To meet this demand, we performed a systematic analysis of CNVs and gene expression in TSGs to provide a systematic view of CNV and gene expression change in TSGs in pan-cancer. Results: We identified 1170 TSGs with copy number gain or loss in 5846 tumor samples. Among them, 207 TSGs tended to have copy number loss (CNL), from which fifteen CNL hotspot regions were identified. The functional enrichment analysis revealed that the 207 TSGs were enriched in cancer-related pathways such as P53 signaling pathway and the P53 interactome.
    [Show full text]
  • Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
    Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
    [Show full text]
  • Network Analysis of Micrornas, Transcription Factors, Target Genes and Host Genes in Human Anaplastic Astrocytoma
    EXPERIMENTAL AND THERAPEUTIC MEDICINE 12: 437-444, 2016 Network analysis of microRNAs, transcription factors, target genes and host genes in human anaplastic astrocytoma LUCHEN XUE1,2, ZHIWEN XU2,3, KUNHAO WANG2,3, NING WANG2,3, XIAOXU ZHANG1,2 and SHANG WANG2,3 1Department of Software Engineering; 2Key Laboratory of Symbol Computation and Knowledge Engineering of the Ministry of Education; 3Department of Computer Science and Technology, Jilin University, Changchun, Jilin 130012, P.R. China Received December 2, 2014; Accepted January 29, 2016 DOI: 10.3892/etm.2016.3272 Abstract. Numerous studies have investigated the roles TP53. PTEN and miR-21 have been observed to form feedback played by various genes and microRNAs (miRNAs) in loops. Furthermore, by comparing and analyzing the pathway neoplasms, including anaplastic astrocytoma (AA). However, predecessors and successors of abnormally expressed genes the specific regulatory mechanisms involving these genes and miRNAs in three networks, similarities and differences and miRNAs remain unclear. In the present study, associated of regulatory pathways may be identified and proposed. In biological factors (miRNAs, transcription factors, target genes summary, the present study aids in elucidating the occurrence, and host genes) from existing studies of human AA were mechanism, prevention and treatment of AA. These results combined methodically through the interactions between may aid further investigation into therapeutic approaches for genes and miRNAs, as opposed to studying one or several. this disease. Three regulatory networks, including abnormally expressed, related and global networks were constructed with the aim Introduction of identifying significant gene and miRNA pathways. Each network is composed of three associations between miRNAs Astrocytoma is a tumor of the astrocytic glial cells and the targeted at genes, transcription factors (TFs) regulating most common type of central nervous system (CNS) neoplasm, miRNAs and miRNAs located on their host genes.
    [Show full text]
  • Expression of MTAP Inhibits Tumor-Related Phenotypes in HT1080 Cells Via a Mechanism Unrelated to Its Enzymatic Function
    INVESTIGATION Expression of MTAP Inhibits Tumor-Related Phenotypes in HT1080 Cells via a Mechanism Unrelated to Its Enzymatic Function Baiqing Tang,* Yuwaraj Kadariya,* Yibai Chen,* Michael Slifker,† and Warren D. Kruger*,1 *Cancer Biology Program and †Biostatistics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 ABSTRACT Methylthioadenosine Phosphorylase (MTAP) is a tumor suppressor gene that is frequently KEYWORDS deleted in human cancers and encodes an enzyme responsible for the catabolism of the polyamine byprod- cell mobility and uct 59deoxy-59-methylthioadenosine (MTA). To elucidate the mechanism by which MTAP inhibits tumor migration formation, we have reintroduced MTAP into MTAP-deleted HT1080 fibrosarcoma cells. Expression of MTAP suppressor genes resulted in a variety of phenotypes, including decreased colony formation in soft-agar, decreased migration, methionine decreased in vitro invasion, increased matrix metalloproteinase production, and reduced ability to form tumors in severe combined immunodeficiency mice. Microarray analysis showed that MTAP affected the expression of genes involved in a variety of processes, including cell adhesion, extracellular matrix inter- action, and cell signaling. Treatment of MTAP-expressing cells with a potent inhibitor of MTAP’s enzymatic activity (MT-DADMe-ImmA) did not result in a MTAP2 phenotype. This finding suggests that MTAP’s tumor suppressorfunctionisnotthesameasitsknownenzymaticfunction.Toconfirm this, we introduced a catalytically inactive version of MTAP, D220A, into HT1080 cells and found that this mutant was fully capable of reversing the soft agar colony formation, migration, and matrix metalloproteinase phenotypes. Our results show that MTAP affects cellular phenotypes in HT1080 cells in a manner that is independent of its known enzymatic activity. Methylthioadenosine phosphorylase (MTAP) is a widely expressed Schmid et al.
    [Show full text]
  • Lack of Methylthioadenosine Phosphorylase Expression In
    Imaging, Diagnosis, Prognosis Lack of Methylthioadenosine Phosphorylase Expression in Mantle Cell Lymphoma Is Associated with Shorter Survival: Implications for a Potential Targeted Therapy Silvia Marce¤ ,1Olga Balague¤ ,1Luis Colomo,1Antonio Martinez,1Sylvia Ho« ller,3 Neus Villamor,1 Francesc Bosch,2 German Ott,3 Andreas Rosenwald,3 Lorenzo Leoni,4 Manel Esteller,5 Mario F. Fraga,5 Emili Montserrat,2 Dolors Colomer,1and Elias Campo1 Abstract Purpose: To determine the methylthioadenosine phosphorylase (MTAP) gene alterations in mantle cell lymphoma (MCL) and to investigate whether the targeted inactivation of the alterna- tive de novo AMP synthesis pathway may be a useful therapeutic strategy in tumors with inacti- vation of this enzyme. Experimental Design: MTAP gene deletion and protein expression were studied in 64 and 52 primary MCL, respectively, and the results were correlated with clinical behavior. Five MCL cell lines were analyzed for MTAP expression and for the in vitro sensitivity to L-alanosine, an inhibitor of adenylosuccinate synthetase, and hence de novo AMP synthesis. Results: No protein expression was detected in 8 of 52 (15%) tumors and one cell line (Granta 519). Six of these MTAP negative tumors and Granta 519 cell line had a codeletion of MTAP and p16 genes; one case showed a deletion of MTAP, but not p16 , and one tumor had no deletions in neither of these genes. Patients with MTAP deletions had a significant shorter overall survival (mean, 16.1 months) than patients with wild-type MTAP (mean, 63.6 months; P < 0.0001). L-Alanosine induced cytotoxicity and activation of the intrinsic mitochondrial- dependent apoptotic pathway in MCL cells.
    [Show full text]
  • Distinct Deletions of Chromosome 9P Associated with Melanoma Versus Glioma, Lung Cancer, and Leukemia 1
    [CANCER RESEARCH54, 344--348, January 15,1994] Advances in Brief Distinct Deletions of Chromosome 9p Associated with Melanoma versus Glioma, Lung Cancer, and Leukemia 1 Aaron Coleman, Jane W. Fountain, Tsutomu Nobori, Olufunmilayo I. Olopade, Gavin Robertson, David E. Housman, and Tracy G. Lugo 2 Division of Biomedical Sciences, University of California, Riverside, California 92521 [A. C., G. R., T. G. L.]; Biology and Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 [J. W. F, D. E. H.]; Department of Medicine, University of California, San Diego, California 92093 [I. N.]; and Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois 60637 [0. L 0.] Abstract lines using probes that detect the IFN-a and D9S126 loci confirms the location of the telomeric 9p breakpoint in line AH between IFN-a and Deletions of DNA on chromosome 9p21-22 are frequently observed in MTAP and suggests that the analogous breakpoint in line FF resides cells derived from melanomas, gliomas, non-small cell lung cancers, and in a location centromeric to MTAP. acute lymphoblastic leukemia. The minimal deletion shared by the latter three cancers extends from the interferon-a locus towards the centromere; Materials and Methods its centromeric end is flanked by the gene encoding methylthioadenosine phosphorylase. We have determined that the telomeric end of the minimal Cell Lines and Culture Conditions. The origin of the human malignant homozygous deletion shared by two melanoma cell lines does not include melanoma cell lines FF (SK-Mel-133) and AH (SK-Mel-13) has been de- the methylthioadenosine phosphorylase locus.
    [Show full text]
  • Integrative Genomics Identifies Molecular Alterations That Challenge the Linear Model of Melanoma Progression
    Published OnlineFirst February 22, 2011; DOI: 10.1158/0008-5472.CAN-10-2958 Cancer Molecular and Cellular Pathobiology Research Integrative Genomics Identifies Molecular Alterations that Challenge the Linear Model of Melanoma Progression Amy E. Rose1, Laura Poliseno1, Jinhua Wang2, Michael Clark1, Alexander Pearlman2, Guimin Wang1, Eleazar C. Vega y Saenz de Miera1, Ratna Medicherla1, Paul J. Christos7, Richard Shapiro3,6, Anna Pavlick4,6, Farbod Darvishian5,6, Jiri Zavadil5, David Polsky1,5,6, Eva Hernando5,6, Harry Ostrer2,4,5,6, and Iman Osman1,4,6 Abstract Superficial spreading melanoma (SSM) and nodular melanoma (NM) are believed to represent sequential phases of linear progression from radial to vertical growth. Several lines of clinical, pathologic, and epidemiologic evidence suggest, however, that SSM and NM might be the result of independent pathways of tumor development. We utilized an integrative genomic approach that combines single nucleotide polymorphism array (6.0; Affymetrix) with gene expression array (U133A 2.0; Affymetrix) to examine molecular differences between SSM and NM. Pathway analysis of the most differentially expressed genes between SSM and NM (N ¼ 114) revealed significant differences related to metabolic processes. We identified 8 genes (DIS3, FGFR1OP, G3BP2, GALNT7, MTAP, SEC23IP, USO1, and ZNF668) in which NM/SSM-specific copy number alterations correlated with differential gene expression (P < 0.05; Spearman's rank). SSM-specific genomic deletions in G3BP2, MTAP, and SEC23IP were independently verified in two external data sets. Forced overexpression of metabolism-related gene MTAP (methylthioadenosine phosphorylase) in SSM resulted in reduced cell growth. The differential expression of another metabolic-related gene, aldehyde dehydrogenase 7A1 (ALDH7A1), was validated at the protein level by using tissue microarrays of human melanoma.
    [Show full text]